Antifungal susceptibility of Saccharomyces cerevisiae and therapy in a murine model of disseminated infection

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of <i>Candida</i> Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion

Michael A. Pfaller, Daniel J. Diekema, David L. Gibbs et al. · Journal of Clinical Microbiology · 2010 · 706 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections

Maiken Cavling Arendrup, Teun Boekhout, Murat Akova et al. · Clinical Microbiology and Infection · 2013 · 524 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +11

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing

Michael A. Pfaller, Daniel J. Diekema, David L. Gibbs et al. · Journal of Clinical Microbiology · 2008 · 369 citations

Life Sciences, Infectious Diseases, Microbiology +17

Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans

Michael E. Klepser, Erika J. Wolfe, Ronald N. Jones et al. · Antimicrobial Agents and Chemotherapy · 1997 · 245 citations · Full text

Medicine, Microbiology, Pharmacology +17

Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus

Peter Warn, Juan Alejandro Neira Mosquera, Jochen Spickermann et al. · Journal of Antimicrobial Chemotherapy · 2006 · 77 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17